Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine for Adults With Immunocompromising Conditions: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Indexed incrossref
Abstract
This document details the new recommendation for utilizing the 13-valent pneumococcal conjugate vaccine in place of the 23-valent polysaccharide vaccine in transplant recipients and the majority of candidates.
Citation impact
690
total citations
- FWCI
- 51.49
- Percentile
- 100%
- References
- 12
Citations per year
Topics & keywords
Topics
Keywords
- Medicine
- Advisory committee
- Immunization
- Pneumococcal conjugate vaccine
- Pneumococcal disease
- Conjugate vaccine
- Pneumococcal polysaccharide vaccine
- Pneumococcal vaccine
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.